Cargando…
Granzyme B Degraded Type IV Collagen Products in Serum Identify Melanoma Patients Responding to Immune Checkpoint Blockade
SIMPLE SUMMARY: Novel biomarkers that can identify melanoma patients responding to immune checkpoint inhibitor therapy are urgently needed. As high T-cell infiltration and low fibrotic activity are associated with response, we aimed to examine the serum biomarker potential of granzyme B degraded typ...
Autores principales: | Jensen, Christina, Sinkeviciute, Dovile, Madsen, Daniel Hargbøl, Önnerfjord, Patrik, Hansen, Morten, Schmidt, Henrik, Karsdal, Morten Asser, Svane, Inge Marie, Willumsen, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601429/ https://www.ncbi.nlm.nih.gov/pubmed/32998446 http://dx.doi.org/10.3390/cancers12102786 |
Ejemplares similares
-
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
por: Jensen, Christina, et al.
Publicado: (2018) -
The minor collagens in articular cartilage
por: Luo, Yunyun, et al.
Publicado: (2017) -
A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity
por: Mortensen, Joachim Høg, et al.
Publicado: (2022) -
Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
por: Thorlacius‐Ussing, Jeppe, et al.
Publicado: (2023) -
In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
por: Drobinski, Patryk J., et al.
Publicado: (2022)